I now have comprehensive data from multiple authoritative sources. Here is a complete answer:
Normal PT/INR Levels in Newborns by Gestational Age
Coagulation reference ranges in neonates differ significantly from adult values and vary with both gestational age (GA) and postnatal age. The most widely cited foundational data come from Andrew et al. (1983-1988 term and 30-36 week studies) and Christensen et al. (2014, for preterm <34 weeks), with more recent 2024 NICU data from Lalos et al.
Table 1 - PT/INR by Gestational Age (Fetal/Cord Blood)
Based on Reverdiau-Moalic et al. (Blood 1996) - cord/fetal blood values:
| Gestational Age | PT (seconds) - Mean (range) | INR - Mean (range) |
|---|
| 19-23 weeks (fetus) | 32.5 (19-45) | 6.4 (1.7-11.1) |
| 24-29 weeks (fetus) | 32.2 (19-44) | 6.2 (2.1-10.6) |
| 30-38 weeks (preterm) | 22.6 (16-30) | 3.0 (1.5-5.0) |
| Term newborn (cord blood) | 16.7 (12.0-23.5) | 1.7 (0.9-2.7) |
| Adult (reference) | 13.5 (11.4-14.0) | 1.1 (0.8-1.2) |
Source: Newborn Critical Care Center Clinical Guidelines, citing Reverdiau-Moalic P et al.
Table 2 - PT Reference Ranges by GA (Upper Limit / 95th Centile)
Based on Christensen et al. (Transfusion 2014) and Andrew et al. - used clinically to define "abnormal":
| Gestational Age | PT (s) 95th Centile (upper limit of normal) | aPTT (s) 95th Centile |
|---|
| <28 weeks | >21 s | >64 s |
| 28-34 weeks | >21 s | >57 s |
| 30-36 weeks | >16 s | >55 s |
| Term (>36 weeks) | >16 s | >55 s |
Source: Pal S et al., "Interpretation of clotting tests in the neonate," Arch Dis Child Fetal Neonatal Ed 2015; Andrew et al. and Christensen et al. 2014.
Table 3 - Most Recent NICU-Derived Reference Intervals (2024)
From Lalos et al. (
J Thromb Haemost 2024, PMID 39271017) - indirect reference intervals from 1,128 neonates in a Level IV NICU:
| Population | PT (seconds) | INR | aPTT (seconds) |
|---|
| Preterm neonates | 10-25 s | 0.7-2.1 | 25-68 s |
| Term neonates | 10-22 s | 0.8-1.8 | 25-58 s |
| All neonates (combined) | 10-24 s | 0.8-1.9 | 25-62 s |
Important finding: These 2024 intervals are substantially wider than older adult-derived ranges used in most labs. Using these gestational age-specific intervals would flag 58% fewer PT and 43% fewer INR results as abnormal compared to current lab reference intervals.
LabCorp Pediatric Reference Ranges (Clinical Labs)
| Age | PT (seconds) | INR |
|---|
| 0-30 days (term newborns) | 9.8-13.2 s | 0.9-1.4 |
| 1-6 months | 9.8-12.6 s | 0.9-1.2 |
Key Concepts to Remember
-
PT/INR is physiologically prolonged in preterm infants due to reduced synthesis of vitamin K-dependent clotting factors (II, VII, IX, X) - a normal developmental finding, not necessarily pathological.
-
INR interpretation caveat: INR was designed for monitoring warfarin therapy. Its validity in neonates is questionable because the ISI (International Sensitivity Index) calibration assumes adult factor levels. An INR of 1.5 in a neonate does NOT mean the same as INR 1.5 in an anticoagulated adult.
-
Postnatal age matters: PT in term neonates tends to stay relatively stable over the first months of life, whereas aPTT starts high and decreases toward adult range over 6 months.
-
Vitamin K at birth: Routine administration of vitamin K (1 mg IM) at birth normalizes PT in healthy term newborns by day 5-7. Preterm infants without vitamin K can have significantly prolonged PT.
-
Avoid over-treating: Multiple studies show that abnormal PT/INR alone in non-bleeding preterm neonates does NOT predict hemorrhage, and
Christensen et al. 2014 found no single coagulation test predicted bleeding in the first week of life.
Practical Summary
| GA | Clinically "Normal" PT | Clinically "Normal" INR |
|---|
| <28 weeks (cord) | up to ~21 s | up to ~3.5 |
| 28-34 weeks | up to ~21 s | up to ~3.0 |
| 30-36 weeks (preterm) | up to ~16 s | up to ~2.5 |
| Term (>36 wks), day 1 | up to ~16 s (mean ~13-17 s) | up to ~2.7 (mean ~1.7) |
| Term newborn, lab cutoff | 9.8-13.2 s | 0.9-1.4 |
Always compare to your institution's own neonatal reference intervals and consider clinical context. A prolonged PT in an asymptomatic preterm newborn who received vitamin K requires a different response than the same value in an actively bleeding infant.